Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000210675 | SCV000262904 | uncertain significance | Inborn genetic diseases | 2013-11-21 | criteria provided, single submitter | clinical testing | There is insufficient or conflicting evidence for classification of this alteration. |
Labcorp Genetics |
RCV000953369 | SCV001099938 | benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000953369 | SCV002545868 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | KDM6B: BP4, BS1 |
Laboratory of Diagnostic Genome Analysis, |
RCV000953369 | SCV001798282 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000953369 | SCV001967768 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003967562 | SCV004786739 | benign | KDM6B-related disorder | 2021-08-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |